Abstract
Men who have Sex with Men (MSM) have been affected disproportionately by the global HIV pandemic. Rates of consistent condom-use are low and there is a need for further biomedical prevention interventions to prevent new HIV infections. Post exposure prophylaxis (PEP) can reduce the risk of HIV, but uptake among MSM is low. Pre-exposure prophylaxis (PrEP), an innovative anti-retroviral-based HIV prevention tool might be an appropriate intervention for MSM who have recently accessed PEP that involves HIV negative individuals taking daily tenofovir+emtricitabine for HIV prevention. 44 MSM, attending a primary health-care level MSM-focused sexual health clinic in Cape Town, South Africa, who had initiated PEP were enrolled in this study. Participants were followed up after 2, 4 and 12 weeks. Self-administered electronic surveys were completed at the initial, 4 and 12 week visit. Barriers and facilitators to accessing PEP and remaining adherent were examined, as was knowledge about PrEP. Thirty-two participants (80 %) were <40 years of age (range 20–65 years). 35 % of the participants reported their reason for requiring PEP as condomless receptive anal intercourse. A further 20 % required PEP following condomless penetrative anal intercourse; 27.5 % required PEP due to a broken condom during receptive anal sex and 2 participants during insertive anal sex. Three participants did not complete 28 days of PEP or were lost to follow up. Over half (58.5 %) of the participants reported being completely adherent to their regime; under a third (31.7 %) reported missing one PEP dose; and 9.8 % reported missing more than one dose. 36/40 (90 %) had heard of PrEP and 30/40 (75 %) indicated that they would use PrEP if it were accessible to them. That we enrolled 44 MSM who accessed PEP from a Department of Health affiliated clinic over 12 months, speaks to the low uptake by MSM of PEP services in South Africa. Adherence was high and demonstrates that adherence support is feasible from a state health clinic. Reported risk behaviors in some high-risk participants did not change over time, demonstrating the need for additional longer-term HIV preventions such as PrEP. PEP users could conceivably be transitioned from PEP to PrEP.
Similar content being viewed by others
References
Smith AD, Tapsoba P, Peshu N, Sanders EJ, Jaffe HW. Men who have sex with men and HIV/AIDS in sub-Saharan Africa. Lancet. 2009;374(9687):416–22.
Lane T, Raymond F, Dladla S, Rasethe J, Struthers H, McFarland W, et al. High HIV prevalence among men who have sex with men in Soweto, South Africa: results from the Soweto Men’s Study. AIDS Behav. 2009;15(3):626–34.
McIntyre JA. The need for HIV prevention interventions for men who have sex with men in Africa. Sex Transm Infect. 2010;86(2):82–3.
Kahn JO, Martin JN, Roland ME, Bamberger JD, Chesney M, Chambers D, et al. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP study. J Infect Dis. 2001;183(5):707–14.
Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med. 1997;337(21):1485–90.
Dolezal C, Frasca T, Giguere R, Ibitoye M, Cranston RD, Febo I, et al. Awareness of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) is low but interest is high among men engaging in condomless anal sex with men in Boston, Pittsburgh, and San Juan. AIDS Educ Prev. 2015;27(4):289–97.
Sonder GJ, van den Hoek A, Regez RM, Brinkman K, Prins JM, Mulder JW, et al. Trends in HIV postexposure prophylaxis prescription and compliance after sexual exposure in Amsterdam, 2000–2004. Sex Transm Dis. 2007;34(5):288–93.
Grant R, Lama JR, Anderson PL, McMahan V, Liu AY, Goicochea P, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.
Institute AH. (2015). Available from: http://www.anovahealth.co.za. Accessed 20 Nov 2015
[cited 2015 20 November]. Available from: http://www.health4men.co.za.
Holzemer WL, Uys L, Makoae L, Stewart A, Phetlhu R, Dlamini PS, et al. A conceptual model of HIV/AIDS stigma from five African countries. J Adv Nurs. 2007;58(6):541–51.
Koblin BA, Team ES. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. The Lancet. 2004;364(9428):41–50.
University of California SF. Report of the South Africa men-who-have-sex-with-men Data Triangulation Project. San Fransisco: UCSF. Global Health Sciences; 2015.
Krakower DS, Jain S, Mayer KH. Antiretrovirals for primary HIV prevention: the current status of pre-and post-exposure prophylaxis. Current HIV/AIDS Rep. 2015;12(1):127–38.
Jain S, Krakower DS, Mayer KH. The transition from postexposure prophylaxis to preexposure prophylaxis: an emerging opportunity for biobehavioral HIV prevention. Clin Infect Dis. 2015;60(suppl 3):S200–4.
http://www.unaids.org/en/resources/documents/2014/90-90-90 2014 [cited 2016].
Pitasi MA, Bingham TA, Sey EK, Smith AJ, Teshale EH. Hepatitis B virus (HBV) infection, immunity and susceptibility among men who have sex with men (MSM), Los Angeles County. USA. AIDS Behav. 2014;18(Suppl 3):248–55.
Fairley CK, Read TR. Vaccination against sexually transmitted infections. Curr Opin Infect Dis. 2012;25(1):66–72.
Acknowledgments
We would like to thank the men who participated in the study, the University of Pittsburgh, Graduate School of Public Health and Anova Health Institute’s Health4Men program for making this work possible. Our thanks to Mr. Glenn de Swardt who was instrumental in developing the idea to explore Post Exposure Prophylaxis and Mr. Grant Cairns who assisted with protocol implementation.
Funding
This research was supported by amfAR, The Foundation for AIDS Research, Grant #108471. A training program for research among MSM in developing world settings and #108801, HIV Research among MSM in Developing World Settings (South Africa).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
All authors have no conflicts of interest.
Ethical Approval
The Institutional Review Board (IRB) at the University of Pittsburgh (PRO13050334) and The Human Research Ethics Committee (HREC) of the University of Cape Town, South Africa (HREC REF: 566/2013) approved study procedures. All procedures were in accordance with the ethical standards of the institutional and national research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The men were reimbursed in this study.
Informed Consent
Informed Consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Hugo, J.M., Stall, R.D., Rebe, K. et al. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis. AIDS Behav 20 (Suppl 3), 357–364 (2016). https://doi.org/10.1007/s10461-016-1536-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-016-1536-1